GlassScriptPhysician profile
Carlos Mercado
NPI 1366444051
$5,293.60
in general payments reported to CMS, 2019-2025
37 companies · $866 in 2025
The $866 reported for 2025 was more than what 75% of Nephrology (Internal Medicine) providers received nationally (typical 2025 total: $311).
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $808 · 2020: $229 · 2021: $519 · 2022: $754 · 2023: $1,137 · 2024: $981 · 2025: $866.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,984.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,983.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $508.83 | 2019-2025 | Ultomiris |
| Amgen INC. | $491.19 | 2019-2025 | Tavneos, Krystexxa |
| Travere Therapeutics, INC. | $391.99 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $367.59 | 2019-2025 | Lokelma, Farxiga, Evusheld |
| Otsuka America Pharmaceutical, INC. | $355.63 | 2019-2025 | Jynarque |
| Opko Pharmaceuticals, LLC | $314.96 | 2019-2024 | Rayaldee |
| Mallinckrodt Hospital Products INC. | $308.52 | 2020-2024 | Acthar |
| Glaxosmithkline, LLC. | $284.94 | 2020-2025 | Benlysta, Nucala |
| Genentech USA, INC. | $251.04 | 2019 | |
| Calliditas Therapeutics US INC. | $204.87 | 2024-2025 | Tarpeyo |
| Bayer Healthcare Pharmaceuticals INC. | $174.10 | 2021-2025 | |
| Vifor Pharma, INC. | $171.12 | 2019-2024 | Veltassa, Korsuva |
| Horizon Therapeutics Plc | $154.01 | 2019-2023 | Krystexxa |
| Ani Pharmaceuticals, INC. | $129.18 | 2023-2025 | Purified Cortrophin Gel |
| Bard Peripheral Vascular, INC. | $121.51 | 2023 | Pristine, Wavelinq |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $117.66 | 2020 | |
| Bioventus LLC | $115.34 | 2023 | Sonicone Clinic |
| Novartis Pharmaceuticals Corporation | $95.63 | 2023-2025 | |
| Fresenius USA Marketing, INC. | $90.44 | 2023-2024 | Korsuva, Velphoro |
| Aurinia Pharma U.S., INC. | $68.94 | 2022-2024 | Lupkynis |
| Daiichi Sankyo INC. | $68.81 | 2022-2025 | Injectafer |
| Takeda Pharmaceuticals U.S.A., INC. | $65.60 | 2020-2025 | Gattex |
| Kci USA, INC. | $59.26 | 2023 | V.A.C. Veraflo, V.A.C. Veraflo Cleanse Choice |
| Genzyme Corporation | $49.61 | 2019-2025 | |
| Lilly USA, LLC | $45.37 | 2024 | Jardiance |
| Ardelyx, INC. | $44.45 | 2024-2025 | Ibsrela |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.14 | 2021-2023 | Jardiance |
| Shire North American Group INC | $36.46 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $26.05 | 2019 | |
| Apellis Pharmaceuticals, INC. | $21.74 | 2025 | Empaveli |
| Mallinckrodt Enterprises LLC | $20.96 | 2019 | |
| Abiomed | $20.00 | 2022 | |
| Alnylam Pharmaceuticals INC. | $19.54 | 2023 | Oxlumo |
| Baxter Healthcare | $15.85 | 2022 | |
| Cormedix INC. | $15.51 | 2025 | |
| Medtronic, INC. | $15.01 | 2023 | Venaseal |
| Akebia Therapeutics INC | $10.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carlos Mercado listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.